Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hubertus, Jochen ^a   Zitzmann, Ferdinand ^a   Trippel, Franziska ^a   Müller Höcker, Josef ^a   Stehr, Maximilian ^a   von Schweinitz, Dietrich ^a   Kappler, Roland ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER ASSOCIATED PROTEIN; DNA; NEURONATIN; ONCOPROTEIN; REGULATOR PROTEIN; SOMATOMEDIN B; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; BINDING SITE; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; INFANT; MALE; MOLECULAR MECHANICS; NEPHROBLASTOMA; NNAT GENE; PRESCHOOL CHILD; PROTEIN DOMAIN; PROTEIN EXPRESSION; PYROSEQUENCING; REGULATOR GENE; SCHOOL CHILD; TRANSCRIPTION INITIATION;

ADOLESCENT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; GENOMIC IMPRINTING; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR II; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SUBSTRATE SPECIFICITY; WILMS TUMOR;

EID: 84879354172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067605     Document Type: Article

References (28)

1. Lewis A, Reik W, (2006) How imprinting centres work. Cytogenet Genome Res 113: 81-89 doi:10.1159/000090818.
2. Hubertus J, Lacher M, Rottenkolber M, Müller-Höcker J, Berger M, et al. (2011) Altered expression of imprinted genes in Wilms tumors. Oncol Rep 25: 817-823 doi:10.3892/or.2010.1113.
3. Ulaner GA, Vu TH, Li T, Hu J-F, Yao X-M, et al. (2003) Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum Mol Genet 12: 535-549.
4. Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, et al. (2001) Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Research 61: 4947-4950.
5. Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, et al. (2005) Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 92: 1574-1580 doi:10.1038/sj.bjc.6602478.
6. Davidoff AM, (2012) Wilms Tumor. Advances in Pediatrics 59: 247-267 doi:10.1016/j.yapd.2012.04.001.
7. Li C-M, Guo M, Borczuk A, Powell CA, Wei M, et al. (2002) Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 160: 2181-2190 doi:10.1016/S0002-9440(10)61166-2.
8. Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, et al. (2008) New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer 47: 386-395 doi:10.1002/gcc.20544.
9. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, et al. (2001) Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 98: 591-596 doi:10.1073/pnas.011528698.
10. Ohlsson R, Cui H, He L, Pfeifer S, Malmikumpu H, et al. (1999) Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity. Cancer Research 59: 3889-3892.
11. Fukuzawa R, Breslow NE, Morison IM, Dwyer P, Kusafuka T, et al. (2004) Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet 363: 446-451 doi:10.1016/S0140-6736(04)15491-3.
12. Wang WH, Duan JX, Vu TH, Hoffman AR, (1996) Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J Biol Chem 271: 27863-27870.
13. Evans HK, Wylie AA, Murphy SK, Jirtle RL, (2001) The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2. Genomics 77: 99-104 doi:10.1006/geno.2001.6612.
14. Schulz R, McCole RB, Woodfine K, Wood AJ, Chahal M, et al. (2009) Transcript- and tissue-specific imprinting of a tumour suppressor gene. Hum Mol Genet 18: 118-127 doi:10.1093/hmg/ddn322.
15. de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, et al. (2004) Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet 364: 1229-1235 doi:10.1016/S0140-6736(04)17139-0.
16. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29: 2002-2007.
17. Edwards CA, Ferguson-Smith AC, (2007) Mechanisms regulating imprinted genes in clusters. Curr Opin Cell Biol 19: 281-289 doi:10.1016/j.ceb.2007.04.013.
18. Dekel B, Metsuyanim S, Schmidt-Ott KM, Fridman E, Jacob-Hirsch J, et al. (2006) Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Research 66: 6040-6049 doi:10.1158/0008-5472.CAN-05-4528.
19. Wijnholds J, Chowdhury K, Wehr R, Gruss P, (1995) Segment-specific expression of the neuronatin gene during early hindbrain development. Dev Biol 171: 73-84 doi:10.1006/dbio.1995.1261.
20. Szabó PE (2012) More than insulator: multiple roles of CTCF at the H19-Igf2 imprinted domain: 1-9. doi:10.3389/fgene.2012.00214/abstract.
21. Ideraabdullah FY, Abramowitz LK, Thorvaldsen JL, Krapp C, Wen SC, et al. (2011) Novel cis-regulatory function in ICR-mediated imprinted repression of H19. Dev Biol 355: 349-357 doi:10.1016/j.ydbio.2011.04.036.
22. Ishihara K, Oshimura M, Nakao M, (2006) CTCF-Dependent Chromatin Insulator Is Linked to Epigenetic Remodeling. Molecular Cell 23: 733-742 doi:10.1016/j.molcel.2006.08.008.
23. Dugu L, Hayashida S, Nakahara T, Xie L, Iwashita Y, et al. (2010) Aberrant expression of tenascin-c and neuronatin in malignant peripheral nerve sheath tumors. Eur J Dermatol 20: 580-584 doi:10.1684/ejd.2010.0996.
24. Xu DS, Yang C, Proescholdt M, Bründl E, Brawanski A, et al. (2012) Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival. PLoS ONE 7: e37811 doi:10.1371/journal.pone.0037811.
25. Dugu L, Takahara M, Tsuji G, Iwashita Y, Liu X, et al. (2010) Abundant expression of neuronatin in normal eccrine, apocrine and sebaceous glands and their neoplasms. J Dermatol 37: 846-848 doi:10.1111/j.1346-8138.2010.00873.x.
26. Revill K, Dudley KJ, Clayton RN, McNicol AM, Farrell WE, (2009) Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma. Endocr Relat Cancer 16: 537-548 doi:10.1677/ERC-09-0008.
27. Singh P, Lee D-H, Szabó PE (2012) More than insulator: multiple roles of CTCF at the H19-Igf2 imprinted domain. Front Gene 3. doi:10.3389/fgene.2012.00214.
28. Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, et al. (2007) Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome. Cell 128: 1231-1245 doi:10.1016/j.cell.2006.12.048.